Vanguard Group Inc

13F Holdings History for MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI)

Symbol: MRVI on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 9.38M shares
Security Ownership: 6.51%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in MARAVAI LIFESCIENCES HOLDINGS, INC. Common Stock (MRVI)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.38M shares of MARAVAI LIFESCIENCES HOLDINGS, INC. Common Stock (MRVI). This represents 6.51% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	6.51%		$18.6M	9.38M			$1.98	13G/A	6/30/2025	29 Jul 2025 13:55:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$22.6M	9.38M	-2,278,394	-19.5%	$2.41	Q2 2025
3/31/2025	0%	0%	$25.8M	11.7M	-162,483		$2.21	Q1 2025
12/31/2024	0%	0%	$64.4M	11.8M	-60,316	-0.51%	$5.45	Q4 2024
9/30/2024	0%	+0%	$98.7M	11.9M	+1,133,130	+10.5%	$8.31	Q3 2024
6/30/2024	0%	+0%	$77M	10.7M	+710,484	+7.08%	$7.16	Q2 2024
3/31/2024	0%	+0%	$87M	10M	+34,232	+0.34%	$8.67	Q1 2024
12/31/2023	0%	0%	$65.5M	10M	-213,388	-2.09%	$6.55	Q4 2023
9/30/2023	0%	0%	$102M	10.2M	-341,685	-3.24%	$10.00	Q3 2023
6/30/2023	0%		$131M	10.6M	-230	0%	$12.43	Q2 2023
3/31/2023	0%	+0%	$148M	10.6M	+169,218	+1.63%	$14.01	Q1 2023
12/31/2022	0%	+0%	$149M	10.4M	+177,381	+1.74%	$14.31	Q4 2022
9/30/2022	0.01%	0%	$261M	10.2M	-220,435	-2.11%	$25.53	Q3 2022
6/30/2022	0.01%	0%	$296M	10.4M	-79,184	-0.75%	$28.41	Q2 2022
3/31/2022	0.01%	0%	$371M	10.5M	-21,392	-0.2%	$35.27	Q1 2022
12/31/2021	0.01%	+0%	$441M	10.5M	+426,670	+4.22%	$41.90	Q4 2021
9/30/2021	0.01%	+0%	$496M	10.1M	+1,758,189	+21.1%	$49.08	Q3 2021
6/30/2021	0.01%	+0%	$348M	8.35M	+2,992,196	+55.9%	$41.73	Q2 2021
3/31/2021	0.01%	+0%	$191M	5.36M	+643,102	+13.6%	$35.64	Q1 2021
12/31/2020	0%	+0%	$132M	4.71M	+4,713,452	NEW	$28.05	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.